Ophthalmology – Phacolytic Glaucoma

Basics

Description

Phacolytic glaucoma is an acute secondary open-angle glaucoma caused by leakage of soluble lens proteins from a mature or hypermature cataract through a lens capsule that is usually clinically intact.

It classically presents with:

• Long-standing severe cataract
• Sudden painful red eye
• Markedly elevated intraocular pressure
• Anterior chamber inflammation
• Open anterior chamber angle

The definitive treatment is:

Removal of the cataractous lens.

Key Clinical Concept

The typical sequence is:

Mature/hypermature cataract → leakage of lens proteins → trabecular obstruction → acute IOP elevation

Inflammatory cells and macrophages contribute to the anterior chamber reaction but are not considered the sole cause of the glaucoma.

Epidemiology

Phacolytic glaucoma is now relatively uncommon where:

• Cataracts are treated early
• Cataract surgery is readily accessible

It remains more common where patients present with:

• Long-standing mature cataracts
• Hypermature cataracts

Most patients are:

• Older adults
• Unilaterally affected

Cataract Association

The classic lens is:

• Mature white cataract
• Hypermature cataract
• Morgagnian cataract

A Morgagnian cataract has:

• Liquefied cortex
• Dense nucleus sinking within the capsular bag

Risk Factors

The principal risk factor is:

Long-standing untreated advanced cataract

Other relevant factors include:

• Limited access to cataract surgery
• Delayed presentation
• Very mature lens changes

Pathophysiology

As a cataract becomes mature or hypermature:

• Lens proteins undergo degeneration
• High-molecular-weight proteins leak through the capsule
• These proteins enter the anterior chamber

Although the capsule appears intact clinically, it becomes sufficiently permeable for protein leakage.

Trabecular Obstruction

Elevated IOP results from impaired aqueous outflow due to:

• High-molecular-weight lens proteins
• Proteinaceous debris
• Macrophages containing lens material
• Inflammatory cells

The angle itself generally remains:

Open

Role of Macrophages

Macrophages are commonly found in:

• Anterior chamber
• Trabecular meshwork

They may contain:

• Phagocytosed lens protein

Older theories considered macrophages the primary cause of obstruction.

Modern understanding favors:

Direct obstruction by leaked high-molecular-weight lens proteins, with macrophages contributing to the inflammatory response.

Associated Uveitis

Lens protein leakage also produces:

• Anterior chamber cells
• Flare
• Proteinaceous material

Therefore phacolytic glaucoma is a form of:

Lens-induced inflammatory glaucoma

History

Typical history:

• Gradual painless visual decline over months or years from cataract
• Followed by sudden:
• Ocular pain
• Redness
• Headache
• Further visual deterioration

There is often no history of:

• Cataract surgery
• Trauma

which helps distinguish it from some other lens-induced glaucomas.

Clinical Presentation

The classic presentation is:

Elderly patient + mature white cataract + acutely painful red eye + very high IOP + open angle

Symptoms

Common symptoms include:

• Ocular pain
• Red eye
• Blurred vision
• Headache
• Halos
• Nausea or vomiting if IOP is very high

Vision may already have been poor because of the cataract.

External Examination

Findings may include:

• Conjunctival injection
• Ciliary flush
• Corneal edema

Severe corneal edema may initially obscure anterior segment details.

Intraocular Pressure

IOP is usually:

Markedly elevated

It can reach levels high enough to cause:

• Corneal edema
• Severe pain
• Optic nerve damage

Anterior Chamber

Typical findings include:

• Cells
• Flare
• Proteinaceous debris
• Floating white particles
• Macrophages containing lens proteins

The reaction may appear intense despite the absence of infection.

White Material in the Anterior Chamber

Characteristic findings may include:

• White clumps
• Flocculent material
• Hyperrefractile particles

in front of a:

Mature or hypermature cataract

Keratic Precipitates

Classic descriptions often emphasize that prominent granulomatous KPs are not typical.

Marked:

• Mutton-fat KPs
• Granulomatous inflammation

should raise consideration of:

• Phacoantigenic uveitis
• Another uveitic process

Lens Examination

The lens usually shows:

• Mature white cataract
• Hypermature cataract
• Liquefied cortex

A Morgagnian lens may show:

• Free or sunken dense nucleus
• Liquefied cortical material

Anterior Chamber Depth

Unlike phacomorphic glaucoma, the anterior chamber is often:

Relatively deep

and the angle is open.

This is a crucial distinction.

Gonioscopy

When corneal clarity allows, gonioscopy typically demonstrates:

An open angle

Possible findings include:

• Proteinaceous material
• Inflammatory debris
• Trabecular pigmentation

Fellow Eye

The fellow eye may also have:

• Advanced cataract

but typically does not have:

• Acute IOP elevation
• Inflammation

unless bilateral advanced cataracts are present.

Diagnosis

Diagnosis is usually clinical.

The key combination is:

• Mature/hypermature cataract
• Open angle
• Elevated IOP
• Anterior chamber inflammation
• Lens protein/debris in aqueous

Laboratory Testing

Routine laboratory testing is:

Not required

unless another cause of uveitis or infection is suspected.

Anterior Chamber Aspiration

Aqueous aspiration was historically used to identify:

• Macrophages
• Eosinophilic lens protein

It is rarely necessary in a classic case.

The diagnosis is generally made clinically.

B-Scan Ultrasonography

B-scan may be useful when the fundus cannot be seen because of:

• Dense cataract
• Corneal edema

It can exclude major posterior segment pathology such as:

• Retinal detachment
• Vitreous hemorrhage
• Intraocular mass

before cataract surgery.

Differential Diagnosis

Important differentials include:

• Phacomorphic glaucoma
• Lens-particle glaucoma
• Phacoantigenic uveitis with glaucoma
• Acute primary angle closure
• Uveitic glaucoma
• Endophthalmitis
• Neovascular glaucoma

Phacolytic vs Phacomorphic Glaucoma

Phacolytic Glaucoma

• Mature/hypermature cataract
• Leakage of lens proteins
• Open angle
• Usually relatively deep anterior chamber
• Inflammatory cells and proteinaceous material

Phacomorphic Glaucoma

• Intumescent swollen lens
• Pupillary block / angle crowding
• Closed or occludable angle
• Shallow anterior chamber
• Lens-induced secondary angle closure

This is one of the most important exam distinctions.

Phacolytic vs Lens-Particle Glaucoma

Phacolytic

• Lens capsule clinically intact
• Mature/hypermature cataract
• Protein leakage
• No preceding surgery or trauma required

Lens-Particle Glaucoma

Occurs after:

• Cataract surgery
• Trauma
• Capsular rupture

and results from direct obstruction by:

Gross lens particles

Phacolytic vs Phacoantigenic Uveitis

Phacolytic

• Mature/hypermature cataract
• Capsule usually clinically intact
• Protein leakage
• Macrophage-rich inflammation
• Open-angle glaucoma

Phacoantigenic Uveitis

• Requires capsular disruption
• Usually follows surgery or trauma
• Granulomatous immune-mediated reaction
• May produce secondary glaucoma

Phacolytic vs Acute Primary Angle Closure

Acute primary angle closure usually shows:

• Shallow anterior chamber
• Mid-dilated pupil
• Closed angle
• No mature cataract requirement

Phacolytic glaucoma generally shows:

• Mature cataract
• Open angle
• Significant inflammatory material

Phacolytic Glaucoma vs Endophthalmitis

Features concerning for infection include:

• Recent intraocular surgery
• Severe pain
• Hypopyon
• Dense vitritis
• Poor red reflex beyond that explained by cataract
• Rapidly progressive inflammation

When infection is plausible:

Endophthalmitis must be excluded urgently.

Treatment Principles

Management has two stages:

1. Rapidly control IOP and inflammation
2. Remove the cataract

Cataract extraction is definitive because the lens is the source of leaking proteins.

Initial IOP Control

Aqueous suppressants are preferred.

Common options include:

• Topical beta-blocker
• Topical carbonic anhydrase inhibitor
• Alpha-2 agonist
• Oral acetazolamide when needed

Systemic Acetazolamide

Oral or IV acetazolamide may be used when:

• IOP is markedly elevated
• Topical therapy is insufficient

Avoid or modify use appropriately in patients with:

• Severe renal disease
• Significant electrolyte disturbance
• Relevant sulfonamide-related concerns

Hyperosmotic Therapy

For severe acute IOP elevation:

• IV mannitol

may be used temporarily.

This is a:

Short-term bridge to definitive lens extraction

rather than definitive treatment.

Topical Corticosteroids

Topical corticosteroids are used to control:

• Anterior chamber inflammation
• Lens-protein-induced uveitis

Examples include:

• Prednisolone acetate

Treatment is subsequently tapered according to clinical response.

Cycloplegia

Cycloplegic drops may be useful when there is:

• Significant anterior uveitis
• Ciliary spasm
• Pain
• Risk of posterior synechiae

Miotics

Pilocarpine is generally avoided.

It may:

• Worsen inflammation
• Promote posterior synechiae
• Increase ciliary spasm

and does not address the principal mechanism.

Prostaglandin Analogs

Prostaglandin analogs are not usually the first choice during intense acute intraocular inflammation.

They may be considered later if persistent glaucoma remains after the inflammatory episode resolves.

Definitive Treatment

The definitive treatment is:

Cataract extraction with removal of the source of lens proteins

and irrigation of proteinaceous material from the anterior chamber as required.

Timing of Cataract Surgery

Initial medical therapy is used to:

• Reduce IOP
• Improve corneal clarity
• Suppress inflammation
• Optimize surgical conditions

However, surgery should not be unnecessarily delayed because:

The cataract remains the source of ongoing protein leakage.

Cataract Surgery

The operative approach depends on:

• Lens density
• Capsular integrity
• Zonular stability
• Corneal clarity
• Surgeon experience

Modern surgery is generally performed using:

• Phacoemulsification when technically feasible
• Manual small-incision or extracapsular techniques in selected very dense cataracts

Surgical Challenges

Hypermature lenses may have:

• Weak zonules
• Fibrotic or fragile capsule
• Liquefied cortex
• Dense nucleus

Increasing the risk of:

• Posterior capsule rupture
• Zonular dialysis
• Dropped lens fragments
• Vitreous loss

After Cataract Extraction

Following removal of the lens:

• Inflammation usually falls rapidly
• Protein leakage stops
• IOP often normalizes

Topical steroids can then be tapered according to:

• Anterior chamber reaction
• IOP
• Corneal status

Persistent Elevated IOP

Some eyes continue to have glaucoma because of:

• Chronic trabecular damage
• Preexisting glaucoma
• Peripheral anterior synechiae
• Steroid response

These eyes may require:

• Long-term topical therapy
• Laser or glaucoma surgery in selected cases

Glaucoma Surgery

Glaucoma surgery is rarely required when the disease is treated promptly.

If IOP remains uncontrolled after cataract extraction and inflammation has settled, options may include:

• Trabeculectomy
• Glaucoma drainage device
• Other glaucoma procedures according to angle and optic nerve status

Cystoid Macular Edema

CME may develop because of:

• Severe anterior segment inflammation
• Cataract surgery

It can be assessed with:

Macular OCT

after the media are clear.

Treatment may include:

• Topical corticosteroid
• Topical NSAID

with escalation in selected cases.

Follow-Up

Initially, follow-up should be:

Very close

to monitor:

• IOP
• Corneal edema
• Anterior chamber inflammation
• Optic nerve status
• Response to medication

After cataract surgery, monitor for:

• Persistent glaucoma
• CME
• Corneal edema
• Posterior segment abnormalities

Optic Nerve Assessment

Once the cornea and media clear, evaluate:

• Optic disc
• RNFL/OCT if possible
• Visual field when appropriate

because prolonged high IOP can cause:

Permanent glaucomatous optic neuropathy

Prognosis

Visual prognosis can be surprisingly good even when presenting vision is extremely poor because much of the visual loss may be due to:

• Dense cataract
• Corneal edema
• Acute IOP elevation

rather than irreversible retinal or optic nerve damage.

Poor Prognostic Factors

Include:

• Prolonged severe IOP elevation
• Advanced glaucomatous optic neuropathy
• Corneal decompensation
• Macular disease
• Retinal disease
• Delayed cataract extraction

Complications

Potential complications include:

• Permanent glaucomatous optic neuropathy
• Chronic ocular inflammation
• Corneal edema
• Posterior synechiae
• Cystoid macular edema
• Persistent secondary glaucoma
• Complications of complex cataract surgery

Ophthalmology Pearls

• Phacolytic glaucoma is an acute secondary open-angle glaucoma caused by leakage of lens proteins from a mature or hypermature cataract.
• The classic patient has long-standing poor vision from a white cataract followed by sudden pain, redness, and markedly elevated IOP.
• The lens capsule is usually clinically intact, despite leakage of soluble proteins.
• High-molecular-weight lens proteins are believed to be the principal cause of trabecular obstruction; macrophages are an important associated finding.
• The anterior chamber often contains cells, flare, and white proteinaceous particles.
• The angle is open, which distinguishes phacolytic glaucoma from phacomorphic glaucoma, where an intumescent lens causes secondary angle closure.
• Lens-particle glaucoma usually follows surgery or trauma with capsular disruption, whereas phacolytic glaucoma does not.
• Initial treatment uses aqueous suppressants, systemic acetazolamide or hyperosmotics when necessary, and topical corticosteroids.
• Cataract extraction is the definitive treatment because it removes the source of leaking lens protein.
• Medical IOP control should optimize the eye for surgery but should not lead to unnecessary delay of cataract extraction.
• IOP usually falls after lens removal, but persistent glaucoma may remain if trabecular or optic nerve damage has already occurred.
• Even an eye presenting with extremely poor vision may recover useful vision if treatment occurs before irreversible glaucomatous or posterior segment damage develops.